🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
60 Servings
Botanical Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

Rosemary (Rosmarinus officinalis) leaf extract
250 mg
📊 Market median: 120.0mg (440 products) 📚 187 studies (Tier A: 1, B: 71)
This product: 80mg

Other Ingredients

Microcrystalline Cellulose Cellulose Croscarmellose Sodium Stearic Acid Silica Coating

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (80% of products) Nutrient (4% of products)

Target Groups

Vegetarian Adult (18 - 50 Years) Women (not pregnant or lactating) Gluten Free

Product Information

📋 Directions for Use

Directions: Take one tablet two to three times daily between meals or as directed by your healthcare practitioner.

⚠️ Warnings & Precautions

Warning: Do not take if pregnant, or nursing, or if you have a history of seizures disorder. Caution: If taking medication, especially blood thinning agents, consult your healthcare practitioner before use.

Keep out of the reach of children.

Do not use before surgery.

🧪 Formulation Notes

GinkgoRose features high quality ginkgo combined with an extract of rosemary leaf to provide support for healthy metal function.

This product is non-GMO, gluten-free, and vegetarian.

This product is non-GMO, gluten-free, and vegetarian.

Support for healthy mental function

Additional Information

Non GMO Project Verified nongmoproject.org

GF Certified Gluten-free

Practitioner exclusive

Product Details

UPC / SKU 7 55571 80007 7
DSLD Entry Date 2020-03-24
Product Type Botanical
Form Tablet or Pill
Brand Metagenics
DSLD ID 216453
Data Updated 2026-04-11

Research Evidence

183 Research Sources
55 Avg Quality Score
86 Systematic Review
78 Meta Analysis
7 Other
4 Clinical Trial
2 Rct
2 Narrative Review
2 Regulatory Source
1 Openfda Safety
A Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2026
B Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2009
B Ginkgo biloba for tinnitus
Meta Analysis The Cochrane database of systematic reviews 2013
B Ginkgo biloba for tinnitus
Systematic Review The Cochrane database of systematic reviews 2022
B Ginkgo biloba for prevention of dementia: a randomized controlled trial
Rct JAMA 2008
B Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: A systematic review and meta-analysis
Systematic Review Frontiers in aging neuroscience 2023
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2013
B The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
Systematic Review Frontiers in aging neuroscience 2020
B Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2026
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2009
View all evidence for Ginkgo →

Compare Similar Products

View all Ginkgo products →